Latest Athersys Inc. Stories

2011-02-10 20:44:10

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem®, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

2011-01-24 11:41:00

CLEVELAND, Jan. 24, 2011 /PRNewswire/ -- Athersys, Inc. (Nasdaq: ATHX), a clinical stage biopharmaceutical company, today announced that its January 11th Retail Investor Conferences.com presentation is available for on-demand viewing.

2011-01-19 14:43:39

Case Western Reserve University School of Medicine and Athersys, Inc. (NASDAQ: ATHX) announced a joint scientific study on spinal cord injury will be published today in the January issue of the Journal of Neuroscience.

2011-01-07 15:17:00

CLEVELAND, Jan. 7, 2011 /PRNewswire/ -- Athersys, Inc. (Nasdaq: ATHX) today announced that its CEO, Dr. Gil Van Bokkelen Ph.D., will present at Retail Investor Confrences.com.

2010-07-28 15:23:00

VANCOUVER, July 28 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) ("Angiotech") and partner Athersys, Inc.

2009-12-21 12:55:00

Athersys, Inc announced today that it has entered into an agreement with Pfizer Inc to develop and commercialize MultiStem for the treatment of Inflammatory Bowel Disease.

2009-06-25 08:11:00

Funding supports multiple commercial, emerging and pilot projects CLEVELAND, June 25 /PRNewswire-USNewswire/ -- The Center for Stem Cell & Regenerative Medicine (CSCRM), comprised of Case Western Reserve University (CWRU), Cleveland Clinic (CC), University Hospitals (UH), and Athersys, Inc.

2008-11-12 12:00:31

CLEVELAND, Nov. 12, 2008 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced the achievement of another clinical development milestone related to its discovery alliance with Bristol-Myers Squibb Company (NYSE:BMY).

2008-11-10 18:00:22

CLEVELAND, Ohio, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its results for the quarter ended September 30, 2008 and provided an update on key clinical development programs, including ATHX-105 and MultiStem.

Word of the Day
  • A poem in which the author retracts something said in an earlier poem.
The word 'palinode' comes from Greek roots meaning 'again' and 'song'.